Simplify Asset Management Inc. Sells 1,059 Shares of Intuitive Surgical, Inc. $ISRG

by · The Cerbat Gem

Simplify Asset Management Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 12.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,640 shares of the medical equipment provider’s stock after selling 1,059 shares during the quarter. Simplify Asset Management Inc.’s holdings in Intuitive Surgical were worth $3,417,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Aaron Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after buying an additional 19 shares during the last quarter. Rise Advisors LLC lifted its position in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after acquiring an additional 20 shares during the period. Pinnacle Bancorp Inc. increased its position in shares of Intuitive Surgical by 4.1% during the second quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock valued at $289,000 after purchasing an additional 21 shares during the period. Vertex Planning Partners LLC increased its position in shares of Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after purchasing an additional 21 shares during the period. Finally, City Holding Co. raised its stake in shares of Intuitive Surgical by 16.1% in the second quarter. City Holding Co. now owns 159 shares of the medical equipment provider’s stock valued at $86,000 after purchasing an additional 22 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $575.40 on Tuesday. The stock’s 50 day simple moving average is $557.87 and its 200 day simple moving average is $507.44. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market cap of $206.27 billion, a PE ratio of 76.11, a price-to-earnings-growth ratio of 5.28 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ISRG shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 22nd. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. The Goldman Sachs Group raised their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn lifted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, BTIG Research increased their target price on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $611.08.

View Our Latest Analysis on Intuitive Surgical

Insider Buying and Selling

In other news, SVP Mark Brosius sold 4,500 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gary S. Guthart sold 28,800 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the completion of the sale, the insider directly owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 114,007 shares of company stock valued at $63,533,844. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).